Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients ( s Healthcare Diagnostic Imaging Speci...)

Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients

s Healthcare, Diagnostic Imaging, Specialized Therapeutics, Hematology/Cardiology and Oncology. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

About Bayer Schering Pharma AG, Germany

Bayer Schering Pharma is a worldwide leading specialty pharmaceutical company. Its research and business activities are focused on the following areas: Diagnostic Imaging, Hematology/Cardiology, Oncology, Primary Care, Specialized Therapeutics and Women's Healthcare. With innovative products, Bayer Schering Pharma aims for leading positions in specialized markets worldwide. Using new ideas, Bayer Schering Pharma aims to make a contribution to medical progress and strives to improve quality of life.

Forward Looking Statements

This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports filed with the Frankfurt Stock Exchange and with the U.S. Securities and Exchange Commission (including its Form 20-F). Bayer assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

This news release also contains "forward-looking statements" of Onyx within the meaning of the federal securities laws. These forward-looking statements include without limitation, statements regarding the timing, progress and results of the clinical development, regulatory processes, and commercialization efforts of Nexavar. These statements are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated. Ref
'"/>

Page: 1 2 3 4 5 6 7
Related medicine technology :

1. Review of Nexavar Data Presented at ASCO 2007- Investor Conference Call on June 4, 2007
2. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
3. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
4. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
5. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
6. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
7. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
8. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
9. The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
10. MabThera Significantly Extends Survival And Cures More Patients With Aggressive Lymphoma Than Chemotherapy Alone
11. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants

Post Your Comments:

(Date:11/6/2009)...swire-FirstCall/ -- Recession in domestic and inte...llied Healthcare Products in the first quarter of ...Sales declines pushed Allied into a loss for the q...45,000, or negative 9 cents per share, compared to...or 3 cents per share. ,, Sales fell about 21 p...

(Date:11/6/2009)... Kaiser Foundation Health Plan, Inc... subsidiaries reported today a combined total oper...ed September 30, 2009, compared to $10.2 billion i... in the third quarter was $336 million, compared t...Net non-operating income was $233 million in the t...

(Date:11/6/2009)...wswire-USNewswire/ -- America,s Specialty Medicine...id-market and smaller innovator pharmaceutical com...the "Affordable Health Care for America Act," intr...aller companies fear that the cumulative effect of...ir efforts to bring new medicines to market. ,...

Breaking Medicine Technology:Recession Continues to Depress Sales at Allied Healthcare Products 2 Recession Continues to Depress Sales at Allied Healthcare Products 3 Recession Continues to Depress Sales at Allied Healthcare Products 4 Recession Continues to Depress Sales at Allied Healthcare Products 5 Recession Continues to Depress Sales at Allied Healthcare Products 6 Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 2 Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 3 Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 4 Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2 MSU lands 242 1 million grant to take part in national autism study 8928 1 MSU lands 242 1 million grant to take part in national autism study 8928 2 3 to 6 months to lose weight gained in pregnancy is normal 8926 1 3 to 6 months to lose weight gained in pregnancy is normal 8926 2 Scienceroll com on an iPhone Application for Cardiopulmonary Resuscitation Training 49493 1

[0] Recession Continues to Depress Sales at Allied Healthcare Products [0] Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results [0] Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962)

...French Plastic Surgeon, Will Present his, UltraS... of Aesthetic Plastic Surgery Meeting in Me...SAN RAMON, Calif., Feb. 10 Renowned,French Plasti...test,findings from clinical experience with UltraS...l Society of Aesthetic Plastic Surgery (ISAPS) mee...

...here,Technologies, Inc. (Nasdaq: EMIS ) announced...d proof of concept that absorption of oral vitamin...hnology was 15-30 times,greater than with the same...phere,s eligen(R) technology is the basis of the c...ic molecules and pharmaceutical compounds., "This...

Other Medicine Technology:Independent Clinical Results Confirm Up to a 7-Centimeter Reduction in Body Circumference Using UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring System 2 Independent Clinical Results Confirm Up to a 7-Centimeter Reduction in Body Circumference Using UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring System 3 Independent Clinical Results Confirm Up to a 7-Centimeter Reduction in Body Circumference Using UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring System 4 Emisphere Technologies Announces Positive Results From Animal Studies on Oral B12 Using eligen(R) Technology 2 Emisphere Technologies Announces Positive Results From Animal Studies on Oral B12 Using eligen(R) Technology 3

Independent Clinical Results Confirm Up to a 7-Centimeter Reduction in Body Circumference Using UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring System Emisphere Technologies Announces Positive Results From Animal Studies on Oral B12 Using eligen(R) Technology

(Date:11/8/2009)...tle is won," said Dr. Charmaine Yoest. ,, WASH...e of 240-194, the Stupak-Ellsworth-Pitts-Kaptur-Da...tion mandates and funding in HR 3962 passed on the...on President and CEO Dr. Charmaine Yoest said, "Th...ro-life Americans across this country who have flo...

(Date:11/8/2009)...wswire/ -- The following was released today by Ran...Nex. ,, Mr. Terry and his associates from arou...lling by abortion out of any health care bill for ...irst step to victory -- a touchdown in the first q...s. Our rejoicing must be tempered by reality. The ...

(Date:11/7/2009)...wswire/ -- Karen Ignagni, President and CEO of Ame... following statement today on House passage of H.R...ehensive health care reform, and we have contribut...haul of how health insurance is provided. Earlier ...ation of pre-existing condition exclusions, no lon...

(Date:11/7/2009)...ling this a "defining moment" for the American Med... Rohack, M.D., today addressed medical students an...cialty societies at the opening of the AMA,s semi-...reform will top the agenda. ,, (Logo: http://...,, "Over the next 72 hours, this AMA House of D...

(Date:11/7/2009)...wswire/ -- Speaker Nancy Pelosi and Democratic lea...owing a Democratic Whip meeting with President Oba...er,s opening remarks: ,, "Thank you very much,... receive the President of the United States on thi... and making progress for the American people. ,...

Breaking Medicine News(10 mins):Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2 Health News:AHIP Statement on House Passage of H.R. 3962 2 Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2 Health News:Pelosi Remarks Following House Democrats' Meeting with President Obama 2

[0] Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People [0] Stupak Amendment Passes in Final House 'Health Care' Bill. A First Step to Victory, but Many Battles Ahead. We Must Rejoice With Caution.[0] AHIP Statement on House Passage of H.R. 3962 [0] AMA President Kicks Off AMA Meeting Focused on Health Reform [0] Pelosi Remarks Following House Democrats' Meeting with President Obama

...sociation,introduces Manicures and Martinis, a new...oung women together in a casual setting over manic...ts" of preserving fertility. It,s,free, relaxing, ...Jamie Grifo, MD, Ph.D., of NYU School of Medicine....

...resting Metabolic Projects,Available for Partnerin...ration (NASDAQ: GENR ) will present at the Windho...ng held November 3-5 at the Lowes Hotel in,Philade... type 2 diabetes and obesity on Tuesday, November ...

...ll/ - Nuvo Research Inc.,(TSX: NRI), a Canadian dr...,development of drug products that are delivered t...dermal drug delivery technologies, today,announced...s on target to resubmit its Pennsaid application t...

...to announce,availability of Body-Jet, an innovativ...d by Human Med based in Germany. Body-Jet is the f...r liposuction option., While traditional liposuct...ion fluid usually required for,standard liposuctio...

...laces Company Seventh in Atlanta Business Chronicl...a, Ga. (Vocus) October 30, 2008-- Atlanta Business... of "Atlanta,s Best Places to Work" for ...-size companies (101-500 employees), according to ...

...y used its traumatic brain injury blog to report o...rived from a brain injury and may cause complete p...ocked-in syndrome, and while it is rare, there is ...source available on the Internet, informed its br...

The American Fertility Association Announces Plan to Help Young Women Preserve Fertility Genaera to Present at Therapeutic Area Partnerships 2008 NUVO announces third quarter 2008 financial results Body-Jet Water-Assisted Liposuction Establishes New Standard for Liposuction and Fat Harvesting Jackson Healthcare Is Named Among "Atlanta's Best Places to Work"LegalView Reports on Rare Traumatic Brain Injury Condition That Could Cause Complete Paralysis of A Victim

Hancock® II Mitral Bioprostheses

Vitality DS VR

Vitality DS

OTI-Scan 3D - 3D B & A Scan - Ophthalmic Ultrasound

Medicine Products:

Hancock® II Mitral Bioprostheses Vitality DS VR Vitality DS OTI-Scan 3D - 3D B & A Scan - Ophthalmic Ultrasound

( s Healthcare Diagnostic Imaging Speci...)Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients,Health